View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Worth two hours of free CPD, the course has eight bitesize modules of between five and 15 minutes.
Each session is designed to improve confidence in cytology, in particular knowing when it is needed and how to take and interpret skin and ear cytology samples.
The course also includes advice on the use of dermatopicals and how to choose between Douxo S3 Pyo and Douxo S3 Calm.
The modules are presented by Natalie Barnard BVetMed, a European Veterinary Specialist in Dermatology, Amy Elvidge, an RCVS Recognised Specialist in Veterinary Dermatology, and Daniel White, a Dermatology Veterinary Nurse.
Emelie Fogelberg BSc DVM MRCVS, veterinary advisor at Ceva Animal Health said: “Skin problems can be challenging, and recurrent skin irritations are particularly frustrating.
"Cytology is essential in the work up of these cases but is often overlooked.
“Our new skin and ear cytology online course will help both vets and nurses become more confident in sample taking and interpretation to support a diagnosis and management plan from the first consultation.”
To register, visit https://veterinarywebinars.com/community/ceva/.
www.douxo.com
Bacteria isolated from human dental units analysed in other studies included Pseudomonas Sp, Mycobacteria and Legionella.
Bob said: "The Care Quality Commission (CQC) would have no hesitation in shutting down practices with the level of contamination we have seen. The dangers are real and significant for our teams as well as for our patients.
"Part of the problem is that dental units produce aerosols which can carry the bacteria into the depths of the lungs, bypassing normal defence mechanisms. Endotoxin levels have also been shown to be very high in untreated units, potentially resulting in problems when surgical extractions are performed.
Bob added: "The good news is that the biofilms which harbour the bacteria are treatable - but simply adding a little chlorhexidine will not do the trick."
Working with industry leaders, www.VetDentist.info has produced a Starter Kit for veterinary practices, which Bob says will clear biofilms and also provides a safe maintenance solution for ongoing use.
Bob says the cost of keeping your dental unit’s water lines safe for staff and patients is around 25-40p per day. Practices can also sign up for a regular monitoring scheme.
For more information and to get a VetDentist Starter Kit, visit www.VetDentist.info.
The company behind the research shall remain nameless because whilst it has a great PR agency which produces some interesting press releases, the tight so-and-sos have never spent so much as a single bean supporting the VetSurgeon.org community with any advertising. And whilst we always publish stories that are of genuine importance and even the odd piece of PR propaganda-puff, we have to draw the line somewhere.
Where was I? Oh yes. 57 of the 100 veterinary surgeons (64 practice owners, 7 senior partners and 29 employed vets) surveyed by the unnamed company said they think their practice could do more to prevent the spread of infection.
79 said they are concerned that they are not consistently following correct hygiene protocols.
54 said they need more staff training and 53 said they want to be able to give staff more time between appointments to allow longer for more thorough disinfection of equipment and surfaces.
The company says its research suggests vets may need to do more to educate pet owners on the threats of poor hygiene and the spread of infection. Only 14 of the 100 veterinary surgeons surveyed believe that pet owners know enough about this, and pets not being vaccinated against disease was the second most common frustration vets felt about owners’ standards of pet care.
An unnamed spokesperson from the unnamed company said: "A busy vets practice is naturally focused on the care and health of its animal patients, however, hygiene standards are a vital aspect of this. With a full schedule of appointments, it can be difficult to effectively ensure all infection control procedures are covered. As a result, it’s easy for vets to overlook the important role laundry has to play as part of this process."
Incidentally, if you'd like to buy laundry equipment from a company that does support VetSurgeon.org, we recommend Eickemeyer.
IVC was formed in 2011, the result of a merger of several independent veterinary hospitals. Under the leadership of David Hillier, and with backing from Summit Partners in 2014, it grew to over 300 practices before being acquired by the Swedish EQT Partners in January 2017.
In August last year the company merged with Evidensia Group, another veterinary corporate group with practices around Europe, bringing the total to more than 850 clinics and hospitals in eight countries.
EQT has reportedly now instructed Jefferies Investment Bank to auction the business in the first week of November.
No word yet on where the auction will take place. If you go, be careful not to scratch your nose at the wrong moment ("1.7 billion from the gentleman at the back. Yes, that's YOU, Sir.").
Comments received from students included: "They are an extremely supportive team that are very keen to teach and get the students involved at every opportunity" and: "They are very good at getting students involved and making them feel like part of the team".
Other winners included Fiona Ridout, pictured right, who won the award for the most engaged veterinary student on EMS placement. She had consistently excellent feedback across all her placements and significantly exceeded the RCVS required number of weeks for pre-clinical and clinical EMS. Feedback comments included: "Fiona has been highly motivated and reliable, always keen to help and gain experience"; "Fiona is one of the best students that we've have ever had"; 'Her clinical knowledge improves each time she visits", and: "Interactions from staff and clients have been impressive".
Golden Valley Vets in Nailsea Park, Bristol won the students’ award for most supportive veterinary nursing placement practice. Comments received from students included: "All the staff were really friendly, welcoming and patient and I left feeling like part of the team", and: "I was actively encouraged and supported with my Nursing Progress Log during my time there".
Megan Piper won the award for the most engaged veterinary nursing student on EMS placement. Megan received excellent feedback from her EMS placements and from her rotations. Feedback comments included: "When Megan qualifies she will make an excellent nurse and a very valued member of any team"; "Megan has consistently demonstrated a professional, motivated approach to her work in practice", and: "Our Referral Vets and Clinical Director were all very sad that she has finished her placement with us, and have invited her to come back once she has qualified".
Veronica Roberts, Senior Clinical Fellow in Equine Medicine at the University of Bristol said: "The University of Bristol believes that EMS prizes encourage and acknowledge student learning in a practical ‘real world’ situation, thus supporting the university in its aim to prepare graduates for day one competencies and life-long learning. We are grateful to practices for the invaluable contribution they make towards student education through offering EMS placements."
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "At Zoetis we are dedicated to supporting animal health through a wide range of quality medicines, vaccines, services and education so we are proud to sponsor these important prizes. They enable winning students to choose a preferred academic resource to help support them during their important first years in practice, while the winning practices can be formally thanked for their invaluable commitment and support."
The RCVS statement, which can be read in full here, highlighted the fact that there is no body of evidence that homeopathy is effective and nor is it based on sound scientific principles. It should therefore be considered as complementary rather than alternative to treatments which are based on sound scientific principles, or for which there is a recognised evidence base.
In fact, the RCVS statement said nothing new. The principle that veterinary surgeons must first prescribe licensed medicines tested for safety and efficacy is enshrined in the Veterinary Medicines Regulations 2013, which say that if there is no veterinary medicine authorised in the United Kingdom for a condition in a particular species the veterinary surgeon responsible for the animal may treat with a veterinary medicine authorised for use in another animal species or for another condition in the same species, or, failing that, either a medicine authorised in the UK for human use, or a veterinary medicine authorised in another member state for use with any animal species in accordance with the Special Import Scheme, or a specially prepared (extemporaneous preparation or special) medicine, or exceptionally a medicine imported from outside the EU.
There are no homeopathic treatments listed by the VMD as 'authorised', just a handful of homeopathic preparations listed as 'registered', something which, as the BAHVS itself points out, means they have not been subjected to the same evaluation as authorised medicines or tested for efficacy.
The BAHVS is fond of using anecdote as evidence of efficacy (see the endorsements at the foot of this page: http://www.bahvs.com/), so one veterinary surgeon has been inviting colleagues to share their experiences of homeopathy causing harm on social media, in order to produce an infographic (pictured above right, click to enlarge) highlighting the very real harm caused when, for example, owners 'vaccinate' against parvo with homeopathic nosodes, only to have a dead litter on their hands.
The draft infographic can be found here.
Do you have a story to add to it? Share it here.
The RCVS has opened a consultation on the future of veterinary specialisation, which includes a proposal that the use of postnominals and titles by veterinary surgeons should be rationalised in order to avoid confusion amongst the public.
The proposals are submitted for comment by the RCVS Specialisation Working Party, which is chaired by former Chief Medical Officer Professor Sir Kenneth Calman.
The Working Party's review was precipitated by a finding that the structure of veterinary specialisation is "confusing and opaque" to both animal owners and the profession (Unlocking Potential - a Report on Veterinary Expertise in Food Animal Production, by Professor Philip Lowe, 2009).
The Working Party has explored the routes to RCVS Recognised Specialist status. It has also looked at the use of 'specialist' more broadly, given the fact that it is not a protected term in the veterinary field, and has considered animal owners' expectations of a 'specialist'.
The Working Party also makes proposals for encouraging more veterinary surgeons to become specialists, given that there are currently only 319 on the RCVS List of Recognised Specialists, out of a UK practising arm of the profession of some 17,400 veterinary surgeons.
The proposals from the Working Party could have far-reaching impact. One suggestion is that all those meeting the criteria for specialist status would also become Fellows of the RCVS (FRCVS) - a status currently only held by those who complete a thesis or exam, or who qualify on the basis of 'meritorious contributions to learning'. There are also proposals that the term 'RCVS Recognised Specialist' be dropped and replaced with the much simpler term 'specialist' or 'veterinary specialist'.
Further proposals include the introduction of a 'middle tier' of veterinary surgeons - potentially to be called 'advanced practitioners' - who would be below full specialist status and subject to periodic revalidation.
There are also recommendations that veterinary surgeons should be obliged to explain referral options to their clients, including the level of expertise of those to whom they are referring cases.
The future of the RCVS subject boards, which currently manage the various Certificate and Diploma examinations, is also considered in the proposals.
The emphasis throughout is on simplification and improvement, according to Professor Sir Kenneth Calman, who said: "New legislation to introduce statutory registration for veterinary specialists would no doubt make things clearer, as it is for doctors and dentists, but, in the meantime, we believe there are a number of actions which the RCVS could take to improve matters."
The consultation paper can be downloaded from www.rcvs.org.uk/consultations, and comments are welcomed from members of the public, veterinary surgeons and veterinary nurses. The closing deadline for comments, which should be sent to RCVS Head of Education, Freda Andrews, on f.andrews@rcvs.org.uk, is Friday 9 December.
Comments received will be considered by the RCVS committees and Council in early 2012.
Centaur Services' veterinary wholesale business has been acquired by AHN International. Centaur was founded in 1964 by a group of veterinary surgeons who wanted to increase their buying power and the range of products available to them. Over the next 44 years the business, which was owned by its veterinary surgeon shareholders, grew to a turnover of nearly £140m. The company has recently completed a 3 year programme of modernisation making it one of the most technologically advanced wholesalers in Europe. In September 2007, Centaur Services announced its intention to list its shares on the Alternative Investments Market (AIM). These plans were initially postponed and finally cancelled when the Centaur shareholders accepted the offer from AHN. Paul Gerring, Centaur Services' Managing Director said: "There has been considerable consolidation in the veterinary market over recent years, particularly amongst manufacturers, and this partnership with AHN provides us with an increased presence in the market. Like Centaur, AHN is a vet-focussed business with plans to be active in the veterinary supply market on a European and global basis. We see plenty of exciting opportunities out there". AHN International was established to form the first global coalition of leading animal health wholesalers and distributors. With nearly 700 employees worldwide, AHN International is committed to presenting the veterinary surgeons with an advanced level of product and services. Headquartered in Raleigh, North Carolina, AHN International will actively build it's network of leading trading companies around the world through acquisitions and business associations.
Veterinary surgeons are being advised against taking a heavy handed approach to hyperthyroidism by key opinion leaders, including Professor Danielle Gunn-Moore, a Specialist in Feline Medicine at the Royal (Dick) School of Veterinary Studies in Edinburgh.
Professor Gunn-Moore said: "Hyperthyroidism is not a condition that develops suddenly. It is a slowly progressive disease. The cat's body adapts to being hyperthyroid over a relatively long period of time. That is why it is best to return it to a euthyroid state in a controlled manner, rather than trying to crash the thyroxine concentration back down to normal as quickly as possible. Too fast a fall in thyroxine concentration can significantly exacerbate renal compromise and may cause serious harm.
"My recommendation is that you should start with a low dose of anti-thyroid medication and increase it if needed, after assessing the initial response to treatment. Any increase should be made in the smallest increments possible."
Dechra Veterinary Products - makers of Felimazole, the first medical treatment licensed in Europe for feline hyperthyroidism - is inviting vets to stand 700/701 at the BSAVA Congress to find out more about the latest thinking and new research which shows that treatment of hyperthyroid cats can result in iatrogenic hypothyroidism, that hyperthyroid cats are significantly more likely to develop azotaemia than euthyroid cats, and that hypothyroid cats that developed azotaemia have significantly shorter survival times.1
Further information on Felimazole is available by calling 01939 211 200 or visiting http://www.dechra.com/
References:1. Williams, T. et al (2010) JVIM 24: 1086-1092
The charity says it joins mounting evidence that brachycephalic cats, including most modern Persians or Exotic Shorthairs, are suffering from a number of health problems, including breathing problems, eye inflammation, skin infections and difficulty eating.
In the study, published open access in the journal PLOS ONE, cat owners were asked to complete a detailed health questionnaire and submit photographs of their cats so that researchers could measure the muzzle ratio and nose position ratio. 1000 valid questionnaires and 373 valid photographs were received.
The research confirmed that flatter-faced cats (of breeds such as the Persian or Exotic Shorthair), were more likely to have breathing problems and that the breathing difficulties were also associated with increased tear staining and a more sedentary lifestyle.
A previous paper, published in the Journal of Feline Medicine and Surgery (JFMS)2 showed how the skulls of brachycephalic cats are actually deformed, especially the nose and jaw.
The charity says that unfortunately, breeds of cat and dog with flat faces are becoming more and more popular, and extremes (of an already abnormal anatomy) can become instant internet celebrities. These breeds and individuals often have large or prominent eyes which are considered by some to be 'cute' because they are baby-like, and the flattened face often has an up-turned or down-turned mouth, which gives it a human or cartoon characteristic of smiling or scowling, such as Grumpy Cat.
Claire Bessant, Chief Executive of International Cat Care said: "It is very depressing to see the life which has been deliberately dealt to some breeds of cats because of a human desire to develop a certain look. I urge cat lovers to speak out and help others to understand that this is not something we should be doing to cats, and not something we should be tolerating.
"One of the best and most beautifully naturally designed animals – the cat – would not normally have any of these problems; we have created them through selective breeding.
"We should not be encouraging people to breed these cats by calling them 'cute', by being amused at their facial characteristics, or by the fact that they snore – rather we need to understand that this is human intervention that is wholly detrimental to the welfare of the cats and is simply cruel.
"International Cat Care takes an ethical view of all cat breeds and our website (http://icatcare.org/advice/cat-breeds) outlines the problems that exist for some breeds, including very flat-faced cats in the Persians and Exotic breeds. Our stance is that we should never deliberately breed cats for any feature or characteristic that impairs their welfare."
References
Sue qualified from Cambridge in 1984 and then spent time in mixed practice in Devon before taking her Certificate and then British and European Diplomas in Veterinary Dermatology.
Sue has been an RCVS and European Specialist for more than 20 years. She has recently been elected as a Fellow of the RCVS for meritorious contributions to clinical practice, is an elected member of the RCVS Council and is the Senior Vice President of the European Society of Veterinary Dermatology.
Sue is the Veterinary Director of two companies: Veterinary Dermatological Ltd, a manufacturer of a range of veterinary dermatology supplements, and Virtual Vet Derms, a veterinary telemedicine company. She has published seven text books as well as writing numerous peer reviewed articles and contributing chapters to both small animal and equine text books. She lectures extensively in Europe and America.
During her Presidency, Sue intends to consolidate everything she believes to be great about the Association. She said: "BSAVA has just completed a three-year strategic plan and my Presidency is going to be all about driving this forward. There are so many new initiatives in the pipeline I can’t wait to get started. I am looking forward to working with my dynamic teams of BSAVA officers and our amazing Woodrow House staff to show just how great BSAVA really is."
Professor Ian Ramsey becomes Vice President.
Bayer Animal Health has launched a next generation fluoroquinolone antimicrobial - Veraflox (pradofloxacin) - for the treatment of bacterial infections in cats and dogs.
Bayer Animal Health's marketing manager Dr Markus Edingloh said: "Veraflox, with its molecular compound pradofloxacin, developed exclusively for veterinary medicine, marks a major leap forward in veterinary antibiotic therapy and patient care.
"Veraflox has an enhanced spectrum of antimicrobial activity which encompasses Gram-positive and anaerobic bacteria. In addition, Veraflox has demonstrated high levels of bactericidal activity against target pathogens including activity against dormant bacteria typically found in chronic infections."
For cats, an oral suspension is available in which a fine-grained ion exchange agent binds to the antibiotic, apparently allowing it to pass the cat's taste buds undetected. Bayer says this innovation has been adopted specifically to ensure the product is palatable to cats, and help ensure owner compliance. The oral suspension comes with a syringe with both millilitre and gramme graduations, to help ensure accurate dosing.
Veraflox oral suspension is indicated for the treatment of upper respiratory tract infections, wound infections and abscesses. The 15mg tablet is also licensed in cats for treating upper respiratory tract infections.
Bayer says that in addition to its other indications, Veraflox is also very effective at combatting anaerobic bacteria that play a major role in aggressive bone destruction in canine periodontal disease, and it is the first fluoroquinolone to be licensed in dogs for the adjunctive treatment of severe infections of the gingiva and periodontal tissues.
In addition to its dental claim for dogs, Veraflox is also indicated for the treatment of wound infections, superficial and deep pyoderma, and acute urinary tract infections. It is given to dogs as a once-daily flavoured tablet.
Dr Edingloh added: "The unique chemistry and way in which Veraflox works gives it superior antibacterial activity compared with existing fluoroquinolones. In addition, during field studies, Veraflox was shown to be superior to other leading antibiotic products.
"Pradofloxacin has been proven to have a wide spectrum of activity, outstanding antibacterial activity, and an excellent safety margin. Its pharmacokinetic features ensure this active ingredient can rapidly get to the site of infection, at which it has a great impact on the pathogen population.
"One of the most common reasons for treatment failure where antibiotics are concerned is lack of owner compliance. The availability of Veraflox as an oral suspension with a graded syringe for cats, will enable more accurate dosing, far easier administration and so ensure higher cure rates.
"The launch of Veraflox is the first major advance in its class, since the introduction of Baytril, the first veterinary fluoroquinolone, over 20 years ago. Veraflox provides vets with more predictability, reliability and peace of mind, especially in difficult to treat infections."
For further information on Veraflox, please contact your Bayer representative or call 01635 563000.
The charge against Dr Irvine was that in July 2017, he failed to discuss with the owners alternative treatment options to dental surgery under general anaesthetic, or the risks of dental surgery under general anaesthetic, and failed to obtain informed consent from the owners for the surgery.
Dr Vasilev was also originally charged with failing to discuss alternative treatment options or the risks of the surgery and failing to obtain informed consent. However, at the outset of the hearing, as a result of new information which came to light, the RCVS opted to offer no evidence in relation to these charges. Mr Vasilev was separately charged with failing to maintain clear, accurate and detailed clinical records in relation to his treatment of the dog.
At the outset of the hearing, Mr Irvine denied all aspects of the charge against him; while Dr Vasilev admitted all aspects of the remaining charge.
The Committee heard how Rupert's dental surgery under general anaesthetic was recommended by Mr Irvine on 10th July and performed by Dr Vasilev on 11th July 2017. After the surgery, Rupert was discharged, but vomited in his sleep that same night. He was brought back to the practice on 12th July, where Dr Vasilev administered antiemetic and antibiotic medication.
However, Rupert continued to vomit over the next five days, and was seen by the practice on 17th July and then on 18th when blood tests were conducted. Rupert’s condition deteriorated as he continued to vomit and lose weight and he was brought back to the practice on 22nd July where he was euthanased by Dr Vasilev.
The Committee heard evidence from Rupert’s owners as well as two expert witnesses. It found the first aspect of the charge against Mr Irvine proven on the basis that there was an inadequate discussion with the owners regarding the option of delaying the dental treatment on Rupert because of his recent ascites caused by congestive heart failure.
The Committee found the second aspect of the charge against Mr Irvine proven on the basis that he had not discussed the risks of Rupert undergoing general anaesthetic given the recent diagnosis of congestive heart failure, following which (in relation to the third aspect of the charge against Mr Irvine), it was therefore found proven that he had failed to gain informed consent.
With all aspects of the charge against Mr Irvine being proven, and with Dr Vasilev admitting the charge against him, the Committee went on to consider if the proven and admitted charges against both amounted to serious professional misconduct.
In respect of Mr Irvine, Stuart Drummond, chairing the Committee and speaking on its behalf, said: "The Committee was not persuaded that the failure to obtain informed consent from [the owner] and discuss matters further with her on 10th July 2017 in the circumstances of this case would amount to serious professional misconduct which would bring the profession into disrepute.
"In the Committee’s judgment, the breach of standards, whilst amounting to professional misconduct, was not serious professional misconduct, in the context of other discussions which had taken place…. The Committee further decided that a finding of serious professional misconduct in this case would be disproportionate having taken into consideration the discussions that Mr Irvine had with [the owner] prior to 10th July 2017 and the fact he was dealing with a complex and changing case.
"The Committee therefore found that Mr Irvine was not guilty of disgraceful conduct in a professional respect."
The Committee noted that Dr Vasilev had admitted breaching the Code of Professional Conduct for Veterinary Surgeons in respect of failing to keep adequate clinical and client records.
However, in mitigation, the Committee considered a number of factors including that, in failing to maintain adequate notes related to Rupert’s treatment, Dr Vasilev had followed the standard of notetaking in the practice as set out by Mr Irvine who was practice principal; that Dr Vasilev had only worked with Mr Irvine in the UK and his record-keeping was limited to working in one practice; that Dr Vasilev admitted his failures at an early stage of the proceedings; that he had made efforts to avoid repetition in the future by undertaking webinars and research; and, that he had shown insight into the need to ensure full communication and detailed note-taking.
Stuart Drummond added: "In relation to Dr Vasilev, the Committee was satisfied that [his] standard of record-keeping was in breach of the Code of Professional Conduct for Veterinary Surgeons and that the breach… amounted to professional misconduct.
"The Committee concluded that the breaches overall, when considering the context and number of mitigating factors, were, in the Committee’s view, insufficient to amount to serious professional misconduct…. Accordingly it found Dr Vasilev not guilty of disgraceful conduct in a professional respect."
The full facts and findings from the case can be found at www.rcvs.org.uk/disciplinary.
For the study, which was funded by the charity Songbird Survival, researchers collected the nests of 103 blue and great tits, and tested them for the presence of 20 insecticides.
Fipronil, imidacloprid and permethrin were the main culprits, detected in 100%, 89.1% and 89.1% of the samples respectively.
Overall, a higher number of either dead offspring or unhatched eggs was found in nests containing a higher number of insecticides, higher total concentration of insecticides or a higher concentration of fipronil, imidacloprid or permethrin, which the authors say suggests contact exposure of eggs to insecticides in nest lining may lead to mortality and lower reproductive success.
The BVA responded by calling for more research and encouraging vets to work with clients to ensure responsible use of parasiticides.
BVA President Elizabeth Mullineaux said: “Parasiticides play an important role in preventing and treating parasites in animals, which if left unaddressed can lead to bigger health and welfare issues in both animals and people.
"But it’s important they are used responsibly, and this work from the University of Sussex and SongBird Survival highlights the need for more research into how parasiticides affect the environment and wildlife and the associated risks.
“Rather than blanket use, we strongly encourage vets and owners to take a risk-based approach to prescribing or recommending these medicines, reflecting an animal’s exposure to parasites."
Reference
The Kennel Club has announced the results of a survey of 329 Breed Kennel Rescue organisations which has revealed that over 50% of dogs given up for rehoming are given up by women, compared to 17% by men and 27% by couples who made the decision jointly.
The Kennel Club said the survey also revealed lifestyle changes, a lack of training and time to look after the family pet adequately are the main reasons why dogs are rehomed.
Caroline Kisko, Kennel Club Secretary, said: "People really need to explore their reasons for wanting a dog in the first place, do the research properly and invest time into training their dog. We are seeing an increasing number of owners being driven by celebrity trends in choice of dog breed, such as the French Bulldog, owned by Millie Mackintosh, Jessie J and Jonathan Ross.
"Every year dogs are abandoned or given up when the novelty wears off. Dogs are a lifelong commitment and anyone considering getting a pet needs to be sure that they will be able to properly care for the animal for the rest of its life."
Kennel Club Breed Rescue organisations last year rehomed over 20,000 dogs, more than Dogs Trust and Battersea Dogs & Cats Home combined. January was revealed to be the busiest month, highlighting the impact of many families being unprepared for getting a dog and potentially still buying them as a Christmas gift, despite advice to the contrary. More than one in three breed rescue organisations reported an increase of dogs needing to be rehomed compared with 2012.
Caroline continued: "Although not as well-known as other organisations, Kennel Club Breed Rescues work incredibly hard to support their breed. They are set up and run by people passionate about dogs and their particular breed in particular. There is a breed rescue organisation for almost every one of the 212 breeds of pedigree dog in the UK, and more than one in three of the breed rescue organisations also accept crossbreeds as well as pedigrees.
"Breed rescue is a fantastic place to consider when looking for a dog. The expert staff and volunteers will often know the full history of the dogs in their care and provide you with invaluable knowledge on the breed and tips for caring for individual dogs to make sure the dogs find a family for life."
A new infographic and educational webinar are now available to share on social media, to increase farmer awareness and provide best practice guidance.
The infographic and webinar explain how vaccination is considered best practice for control of the disease, giving better disease control whilst ensuring responsible use of antibiotics.
Independent sheep veterinary consultant Dr Fiona Lovatt, who leads the cross-industry Sheep Antibiotic Guardian Group, said: "Despite EAE being responsible for over 35% of all abortion diagnoses, only one million of the 3.5 million replacement ewes in the national flock each year are vaccinated against EAE. Any sheep farmer that either buys in ewes for replacements or has close neighbours that also lamb sheep, risks bringing enzootic abortion into their flock.
"Once the disease infects an unvaccinated flock, some ewes are ‘programmed’ to abort at their next lambing, leaving no choice but to put remedial measures in place – usually including both vaccination and antibiotic treatment.
"This means EAE is a disease that, once in a flock, carries high costs both financially and emotionally in terms of lamb losses and farmer stress. Hence it is important that flocks receive appropriate vaccination at least four weeks before ewes go to the ram and avoid the inappropriate use of antibiotics closer to lambing."
Fiona points out that a single dose of EAE vaccine costs about £2.40 and is an investment that effectively lasts the ewe for her lifetime in the flock, protecting against losses. In contrast, abortion or stillbirth – which accounts for around a quarter of all lamb losses each year – costs over £25 for every single lost lamb.
Fiona added: "Every injection of antibiotics also costs an additional £1. But is just a ‘sticking plaster’ with short-lasting effectiveness in terms of disease control but long-lasting damage in terms of mounting resistance."
Ceva says it will continue to work closely with veterinary practices to secure stock of Cevac Chlamydia vaccine to ensure farmers can purchase and use the vaccine at the right time. Ceva also provides subsidised blood sampling for diagnostic purposes.
For further information, call Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
Photo: Mike Benjamin
The drug monographs for both formularies were revised and updated by the editorial panels in 2022, so the new edition contains the most up-to-date information about the medications used for dogs, cats and exotic pets.
The new formularies contain new drugs, new drug monographs, updated antimicrobial guidelines, parasiticide guidelines and sedation protocols.
The new formularies are available to buy at the BSAVA Publications stand at Congress, with a special 20% Congress discount.
Eligible members who are attending Congress can collect their copy of the BSAVA Small Animal Formulary, 11th edition – Part A: Canine and Feline from the Exhibition Hall.
Any eligible members who are not going to BSAVA Congress will be sent their printed copy from April 2023 onwards.
Eligible members will be sent their printed copy of the BSAVA Small Animal Formulary, 11th edition – Part B: Exotic Pets from April 2023 onwards.
All BSAVA members have access to the online version via the BSAVA Library and the BSAVA app.
Both Part A and Part B are available in print from www.bsava.com/shop (£55; £35.75 to BSAVA members), or as part of a 12-month digital subscription from www.bsavalibrary.com/formulary with Part A: Canine and Feline, Part B: Exotic Pets and the client information leaflets (£256 + VAT; free to BSAVA members).
Michael qualified from the University of Glasgow in 2009 and then worked in first opinion practice in Buckinghamshire and Northern Ireland. He then returned to the University of Glasgow in 2012 to further his training and experience in oncology by completing four years of additional training. He completed an ECVIM residency in oncology in 2016 and became a Diplomate of the European College of Veterinary Internal Medicine and a European Specialist in Oncology in 2017. Michael worked at a private referral practice in Surrey prior to joining Fitzpatrick Referrals. Earlier this year, Michael was awarded a Masters degree in Veterinary Medicine. This additional qualification researched canine mast cell tumours.
Michael said: "I am absolutely delighted to have joined Fitzpatrick Referrals Oncology and Soft Tissue hospital. I have had a long-standing ambition to work as part of the fantastic team here since visiting the hospital during my specialist training in 2015. At this visit, I immediately felt at home in a group of people driven to deliver the very best compassionate care for dogs and cats.
"My ambition is to develop the very best ways to minimise the impact that cancer has on animals. I know that Fitzpatrick Referrals is the best environment for me to be able to achieve this. Throughout the hospital, there is an amazing positive attitude and a collective drive to improve the overall care we can give to pets with cancer. I am also excited by the opportunity to be able to help others to achieve their goals in improving cancer care for pets."
Rominervin contains 10 mg/ml romifidine hydrochloride, equivalent to 8.76 mg romifidine, presented in a 20 ml vial.
It can be used as a sedative to facilitate handling, examination, minor surgical interventions and minor procedures or as a premedication prior to administration of injectable or inhalation anaesthetics.
Rominervin can also be used in combination with synthetic opiates such as butorphanol to provide deeper sedation or analgesia.
Dechra Brand Manager Emma Jennings said: "Rominervin is highly effective as it has a longer duration of action than other alpha-2 agonists1. It starts to work within one to two minutes with maximum sedation achieved between five and 10 minutes.
"It is yet another valuable addition in our equine anaesthesia and analgesia range that has been designed to provide vets with the therapies they need to operate successfully in day-to-day practice."
Rominervin can be used in conjunction with Dechra’s equine anaesthesia and analgesia app, designed to help veterinary professionals choose optimal anaesthetic protocols and calculate anaesthetic drug doses and administration rates.
For more information visit: www.dechra.co.uk/products/equine
The new Veterinary HPM Adult Neutered Wet with Salmon (a lifestage diet) and Urology Cat Wet (a clinical diet) have a high-protein low-carbohydrate formulation and a high share of animal protein.
Virbac points to studies which show that FLUTD is diagnosed in 8% of cats seen by vets for non-routine appointments1 and that there is a 51% risk of recurrence within one year of the initial diagnosis2.
Dr Rémi Mandray DMV MRCVS, Product Manager at Virbac, said: "Feline specialists recognise the importance of nutrition and water intake in the management of FLUTD, so we are delighted to be able to add two high quality wet diets to the Veterinary HPM range and therefore offer advanced nutritional solutions to such an important health issue."
Virbac says that both diets have high levels of animal protein to stimulate water intake, increase the volume of urine and stabilise the pH for a healthy urinary system.
The lifestage diets include supplements to limit phosphorus excretion in the urine for improved prevention of struvite crystal formation.
The company also says the Urology diets in the clinical range meet the PARNUT requirements for dissolution and prevention of struvite stones or crystals, and prevention of oxalate formation.
Virbac claims the new chunks in gravy wet diets naturally increase water intake by up to 50%, due to their high water content.
Dry and wets can be fed together as part of a mixed nutritional programme, to meet pet owner preferences identified in Virbac's market research: 60% of cat owners use wet food, mostly mixed with kibbles4.
For more information, contact your Virbac Territory Manager.
A few examples of the products in J.A.K Marketing's 'ThinkGreen' portfolio include the Purfect Anaesorber, BAG’EMS biodegradable poop bags, Tick Twister products (made from recycled plastic) and Bamboo stick cotton buds.
The website also gives a snapshot of the sorts of things that J.A.K itself does to reduce its impact on the environment, including the use of environmentally-friendly brown paper and recycled cardboard boxes for packaging. The company has also switched to certified sustainable FSC paper for most of its printed marketing materials (including the master catalogue) and is working with courier companies who have targets in reducing CO2 emissions.
Managing Director, John Holland said: "J.A.K Marketing is committed to the protection and preservation of the world’s ecosystem. By undertaking our productivity and operations responsibly and sustainably, we recognise that reducing the environmental impact of our activities is very important. We will strive to achieve environmental excellence within the veterinary industry and will continue to work closely with our employees and commercial partners to establish and follow the principles of our ThinkGreen policy."
Sales Director, James Johnson said: "With growing interest towards the protection of the environment, we need to make it easier for veterinary practices to identify products where there is a benefit to the environment by simply switching to a like for like ‘greener’ alternative. As part of our long-term strategy, we are dedicated to growing this area of our business, welcoming feedback from the profession of how we can all work together to achieve this."
Those wanting to offer inspiration and feedback can do so on the form at the bottom of the ‘ThinkGreen’ page: www.jakmarketing.co.uk/thinkgreen.
Dechra Veterinary Products has announced that it will be launching Zycortal, a new medication for the treatment of canine hypoadrenocorticism at the BSAVA Congress in April.
Zycortal is a prolonged-release suspension used as replacement therapy for mineralocorticoid deficiency in dogs with Addison’s disease. Dechra says it has proved highly effective in clinical trials with more than 80% of dogs responding positively to treatment1.
Zycortal contains desoxycortone pivalate (DOCP) which Dechra says controls serum electrolytes more effectively than fludrocortisone2 (the human treatment currently prescribed for dogs with Addison’s disease) and is considered the preferential drug for mineralocorticoid supplementation.
Zycortal is the only European licensed treatment for canine hypoadrenocorticism and adds to Dechra’s existing endocrinology range.
Visitors to the BSAVA Congress will be able to find out more about Zycortal at the Dechra stand (500). Delegates are also invited to attend a presentation by Professor Ian Ramsey BVSc PhD DSAM DipECVIM-CA FHEA MRCVS on Saturday, April 9, at 11.10am.
The presentation, New developments in the diagnosis and management of Addison’s disease aims to give delegates an insight into the condition.
Dechra Brand Manager Craig Sankey said: "We are very excited to be able to bring Zycortal to veterinary professionals in the UK. Addison’s disease can be very hard to diagnose as it mimics so many other illnesses.
"Each injection of Zycortal lasts approximately one month, providing long-term control of primary Addison’s disease. The prognosis for dogs with Addison’s disease is excellent provided that treatment is maintained for life. Our team will be on hand at the BSAVA Congress to explain and discuss the benefits that Zycortal can bring to their day to day practice in the fight against this illness."
Veterinary medicines are defined in the Veterinary Medicines Regulations as:
"any substance or combination of substances that may be used in, or administered to, animals with a view either to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis."
On this basis, the VMD says CBD products for use in animals require a marketing authorisation before they can be sold or supplied in the UK.
There are currently no CBD based products that have been granted a UK veterinary marketing authorisation which means that under the cascade, veterinary surgeons must prescribe a legally obtained human CBD product.
Photo: Shutterstock / Lifestyle discover
Publishing Editor Arlo Guthrie said: "I've lost count of the number of vets who remark that all veterinary recruitment adverts say that there's a 'happy working team' or a 'supportive environment', or 'all the latest toys' and it's only when they arrive at the practice that they discover that everyone's at each other like ferrets in a sack, and the practice's idea of 'all the latest toys' is a 1972 Goblin Teasmade."
VetSurgeon Jobs now includes the ability for advertisers to display in their advert links to the VetSurgeon profiles of other employees at the practice who are prepared to have an informal chat with candidates about what it's like working there.
Using the messaging system on VetSurgeon.org, the potential applicant and the employee can then arrange a time for a chat, without revealing the employee's email address, after which the candidate will hopefully feel far better placed to decide whether it's the job for them.
Arlo said: "Of course, no advertiser is going to display the name of an employee who is going to say bad things about the practice, but it still offers the chance for candidates to ask questions and make their own mind up before applying for an interview."
Aside from that, just the fact that a practice shows that it has the confidence in its employees to put them in touch with potential candidates says something very positive about those practices which use the feature.
To use the new feature, job advertisers need to enter the email address of another employee at the practice who is also a member of VetSurgeon.org and has agreed to talk to candidates, when they place their advertisement. When it goes live, the advert will then contain a direct link to the employee's profile, under the title: "Talk to other employees of this practice."
Fort Dodge Animal Health has announced that the European Medicines Agency (EMEA) has approved a new label claim for ProMeris Duo® for dogs. The new claim extends protection offered by ProMeris Duo to include "treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs".
Accoding to the company, dealing with demodectic mange on a dog has in the past been time-consuming for the pet owner and sometimes required vets to use a product off-label. Despite available measures, some dogs fail to respond to treatment and even require euthanasia due to the severity of the condition.
Rami Cobb, BVSc (Hons), MACVSc, Senior Vice President of Pharmaceutical Research and Development at Fort Dodge Animal Health said: "With the addition of the demodectic mange claim to the ProMeris Duo label, vets have the option of using the recognized efficacy of amitraz in a convenient spot-on formulation to treat and control this condition.
"When we conducted field studies for the label claim, the before and after pictures of the dogs treated with ProMeris Duo were remarkable. Visible improvements in the dog's condition were seen following the first treatment and in most cases, demodex mites could not be found after just a few months."
ProMeris Duo was evaluated for efficacy against demodectic mange mites in naturally infected dogs. Study results indicated dogs treated monthly with ProMeris Duo showed significant reduction in mite numbers and improvement in clinical signs after three months.
ProMeris Duo is now licensed for the following indications: For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), as well as ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).